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Conference: Prevention of Human Cancer 
Introduction 
Chemoprevention is a strategy to block cancer development hrough the use of 
chemical agents, some of which currently are considered nutrients and others 
which are clearly synthetic pharmacological compounds. Thus, chemoprevention 
is analogous to chemotherapy in the treatment of cancer. Hindrance or modifi- 
cation of each stage of the carcinogenic process-initiation, promotion, and pro- 
gression-has been accomplished in vitro and in animal models. Translating this 
approach to human beings represents a formidable task. Although there is reason 
to believe that the general process of carcinogenesis should be similar in all 
species, several observations indicate that this assumption may have to be qual- 
itatively and quantitatively modified for human beings: 
l Metabolism of carcinogens by different species varies. Also, man is not an 
inbred species and therefore exhibits genetic and phenotypic heterogeneity in 
response to carcinogens; 
l Acute one-time application of an initiator followed by multiple exposures to a 
promoter at relatively high to very high doses is the usual experimental carcino- 
genesis protocol. Actual interaction of chemicals with humans is unlikely to fol- 
low this convenient pattern. Exposure to multiple low doses of many carcinogens 
over a long period of time represents the more likely scenario; 
l Dietary and environmental variables in animal experiments can be well de- 
lineated in appropriately designed trials. Modification of dietary and cultural vari- 
ables in free-living individuals is very difficult; 
l Compliance of cells or animals to the experimental plan is not an issue; ad- 
herence of subjects who are basically well, to a prevention protocol can be quite 
difficult. 
In the early 1980s a number of investigators began to explore the feasibility of 
chemoprevention in human beings and several trials were launched. These trials 
represented formidable undertakings with sample sizes larger than most thera- 
peutic phase III trials. Additionally, long follow-up times were needed for enough 
endpoints to occur that would allow for differences in the control and intervention 
arms of the trial to develop. New strategies have evolved to address the differ- 
ences in experimental design, statistical evaluation, recruitment, agent selection, 
and outcome measurements inherent to chemoprevention trials. 
The first conference in Tucson in 1982 dealt with vitamins as potential preven- 
tive or therapeutic anticancer agents; in 1985 the focus was primarily on the 
retinoids. The current conference in 1988 was directed toward exploration of the 
relevant scientific basis and methodological issues for chemoprevention in hu- 
mans. 
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The papers which form these proceedings should provide an important resource 
for where we are in this field and where we need to go. Additionally, new inves- 
tigators to this field will find the presented information useful and necessary as a 
basis for their own trials. We look forward to our next meeting in 1991 by which 
time our understanding of the biology of early transformation of human cancers 
will be more substantial, many chemoprevention trials should have matured to 
provide definitive answers, and new second-generation trials will have been 
launched. 
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